Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,475 | 7,779 | 11,767 | 15,944 | 20,435 |
| Receivables | 134 | N/A | 12 | 64 | 86 |
| TOTAL | $5,775 | $7,887 | $11,915 | $16,532 | $20,588 |
| Non-Current Assets | |||||
| PPE Net | 46 | 68 | 96 | 128 | 20 |
| Other Non-Current Assets | 11 | 11 | 21 | 20 | 12 |
| TOTAL | $56 | $79 | $118 | $148 | $32 |
| Total Assets | $5,832 | $7,966 | $12,033 | $16,680 | $20,620 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106 | 250 | 333 | 220 | 448 |
| Accrued Expenses | 193 | 45 | 1,097 | 83 | 325 |
| TOTAL | $299 | $294 | $1,430 | $303 | $773 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15 | 54 | 43 | 54 | 0 |
| TOTAL | $15 | $54 | $43 | $54 | $N/A |
| Total Liabilities | $314 | $349 | $1,473 | $357 | $773 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,655 | 18,043 | 14,165 | 12,564 | 12,528 |
| Common Shares | 19 | 18 | 14 | 13 | 13 |
| Retained earnings | -31,712 | -27,705 | -20,463 | -9,899 | -5,759 |
| TOTAL | $5,518 | $7,618 | $10,560 | $16,323 | $19,847 |
| Total Liabilities And Equity | $5,832 | $7,966 | $12,033 | $16,680 | $20,619 |